Beta-Defensin-1 (1-36), HBD-1 Human Synthetic Control Peptide

Detailed list of information related to product

About product

Catalog number:DEF001-P
Name:Beta-Defensin-1 (1-36), HBD-1 Human Synthetic Control Peptide
Size:100 µg
Go to shop   

Extra details

Availability:Please contact us to check the availability
Specificity:Synthetic human peptide ß-Defensin-1 (HBD-1): Asp-His-Tyr-Asn-Cys-Val-Ser-Ser-Gly-Gly-Gln-Cys-Leu-Tyr-Ser-Ala-Cys-Pro-Ile-Phe-Thr-Lys-Ile-Gln-Gly-Thr-Cys-Tyr-Arg-Gly-Lys-Ala-Lys-Cys-Cys-Lys(Disulfide bonds between Cys5-Cys34, Cys12-Cys27, and Cys17-Cys35)
Species reactivity:-
Product presentation:Synthetic peptide lyophilized from acetic acid
Product category:Control Peptide
Antibody's raised in:Human, synthetic
Antibody's isotype:-
Antibody's clone:-
Product is supplied as:lyophilisate
Recommended concentration for use:-
Protein concentration:-
Positive control:-
Tested applications:Control peptide
Recommended secondary reagent:none
Storage method:Store at -20'°C'
UniProt number:Go to UniProt/SwissProt
Litterature:1. Bensch K.W., Raida M., Mägert H.J., Schulz-Knappe P., and W.G. Forssmann. HBD-1: a novel beta -defensin from human plasma. FEBS Lett 1995, 368; 331-335. (original publication HBD-1) 2. M.J. Goldman, G.M. Anderson, E.D. Stolzenberg, U.P. Kari, M. Zasloff, and J.M. Wilson, Cell, 88, 553 (1997). (Pharmacol.; Inactivated in Cystic Fibrosis) 3. T. Hiratsuka, M. Nakazato, T. Ihi, T. Minematsu, N. Chino, T. Nakanishi, A. Shimizu, K. Kangawa, and S. Matsukura, Nephron, 85, 34 (2000). (Pharmacol.)
Tips:Gentaur products are intended for in vitro research use only. They must not be used for clinical diagnostics and not for in vivo experiments in humans or animals.
Description:Isotype or positive controls by peptides, antibodies and deactivated samples.human, mouse or other beta β- and alpha α- defensins are expressed by neutrophils ( α- ), lymphocytes and epithelial cells. DEFA DEFB genes defend the host against pathogens. GENTAUR supplies anti-defensins, monclonals, polyclonals antisera and recombinant DEFs or peptides of defensin.Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.
Properties:Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.

Other suggested products